Yunnan genuine medicine "37" goes against the trend to rise the sky price

Business news on May 21 recently, Yunnan genuine medicinal material Sanqi is one of the highlights of the pharmaceutical market In the overall poor market environment, Sanqi bucked the trend and the price rose sharply in a short time, creating a sky high market Because the price is rising too fast, many businesses stop to wait and see As a result, after nearly two months of soaring price, the market of March 7th has turned stable in the past two days Now, 120 goods in Wenshan County have exceeded 700 yuan / kg This price rise has reached a peak Is it just entering a short period of correction and consolidation? From 2000 to 2008, the price of March 7th was kept below 100 yuan The low price all year round has seriously dampened the enthusiasm of drug farmers With the production decreasing year by year, 37 finally ushered in a bright future in 2009, with the market climbing steadily, breaking through 200 and 300 yuan one after another In 2010, Yunnan's severe drought and financial intervention pushed the price of March 7th to soar, breaking the 500 yuan mark With the intervention of the national development and Reform Commission, the price of March 7th fell to 230 yuan at the lowest, but the rigid demand of the market made its price get support around 300 yuan Although the drug market bear market came in 2011, although there was a small fluctuation in the market, but the price has been maintained at more than 300 yuan In 2012, the March 7th market reappeared Starting from March, the price rose from 420 yuan to 740 yuan, up 76.2%, especially nearly 200 yuan in the past month The speed and scope of the price rise are unexpected Panax notoginseng is an important procurement raw material for Yunnan Baiyao, Heilongjiang Zhenbaodao, Guangzhou Baiyunshan, Tianjin Tianshili and other pharmaceutical products, while there are more than 400 kinds of Chinese patent medicines with Panax notoginseng as raw material In recent years, with the enhancement of people's health awareness, 37 has been widely used, and its demand has increased year by year The annual demand of 37 is about 7000 tons 97% of the country's Sanqi is produced in Yunnan Province, with the total output of about 5000 tons in 2011 Under the condition of high price in recent two years, dealers choose to work hard and sell fast to avoid risks The market inventory is not large and the gap between production and demand is not filled The main reason for this increase is the contradiction between production and demand The growth cycle of Panax notoginseng is three years and it can't be continuous cropping Although the planting area has increased from 2009 to 2011, the late spring cold in 2010 and the drought in Yunnan in recent years are bound to have an impact on the growth of Panax notoginseng Moreover, the expansion in 2009 will produce new products in September this year, and the contradiction between supply and demand before the new production is difficult to ease In the previous two years, the price of March 7th was already high Pharmaceutical companies waited for the price to fall and started to source goods, but did not conduct a large amount of reserves Although the current high price market has restrained the movement of goods sources, some small pharmaceutical companies have stopped production and purchase due to high cost, but for large pharmaceutical companies, in order to maintain the market share of the brand, even if it is expensive, they have to purchase hard This part of demand may become the support for the stable operation and even further increase of the 37 market Under the strong support of the fundamentals, the price before the new production will still be stable and rising However, in the future, we must be alert to the high and cold, the rapid rise in the short term, whether the pharmaceutical enterprises will reduce the actual purchase volume, and whether the retail link will shrink seriously, which will directly affect the future market and trend of 37.